Humacyte Inc. held its Annual Meeting of Stockholders on June 10, 2025. During the meeting, stockholders voted on several proposals. The election of four Class I directors was approved. An amendment to the Certificate of Incorporation to increase the number of authorized shares of common stock from 250,000,000 to 350,000,000 was also approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Humacyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001818382-25-000080), on June 11, 2025, and is solely responsible for the information contained therein.